InMed Pharmaceuticals (INM) Inventory Average (2022 - 2025)
InMed Pharmaceuticals (INM) reported Inventory Average of $919352.5 for Q4 2025, down 20.86% on a YoY basis from $1.2 million in Q4 2024, and down 0.72% quarter-over-quarter from $925990.0 in Q3 2025.
InMed Pharmaceuticals (INM) Inventory Average (2022 - 2025) Analysis & Trends
InMed Pharmaceuticals has reported Inventory Average for 4 years, with the latest figure at $919352.5 in Q4 2025.
- For the quarter ending Q4 2025, Inventory Average fell 20.86% year-over-year to $919352.5; the trailing twelve-month figure through Dec 2025 stood at $919352.5 (down 20.86% YoY), and the FY2025 full-year result was $1.1 million, down 22.9% from the prior year.
- Inventory Average for Q4 2025 stood at $919352.5, down from $925990.0 in the prior quarter.
- The five-year high for Inventory Average was $2.1 million in Q3 2022, with the low at $887571.5 in Q2 2025.
- Historically, Inventory Average has averaged $1.3 million across 4 years, with a median of $1.2 million in 2022.
- Annual changes were most pronounced in 2023 — Inventory Average slumped 44.64% — and 2024, when it advanced 23.72%.
- InMed Pharmaceuticals' Inventory Average stood at $1.7 million in 2022, then tumbled by 44.64% to $938968.0 in 2023, then gained by 23.72% to $1.2 million in 2024, then declined by 20.86% to $919352.5 in 2025.
- The last three Inventory Average figures came in at $919352.5 (Q4 2025), $925990.0 (Q3 2025), and $887571.5 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3.18 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.51 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 180.70 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 131.60 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 66.75 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.73 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 266.66 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 63.01 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 79.60 Mn |
| 10 | InMed Pharmaceuticals | 6.00 Mn | 756,271.05 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 919,352.50 |
| Sep 30, 2025 | 925,990.00 |
| Jun 30, 2025 | 887,571.50 |
| Mar 31, 2025 | 958,663.00 |
| Dec 31, 2024 | 1.16 Mn |
| Sep 30, 2024 | 1.23 Mn |
| Jun 30, 2024 | 1.22 Mn |
| Mar 31, 2024 | 969,395.50 |
| Dec 31, 2023 | 938,968.00 |
| Sep 30, 2023 | 1.37 Mn |
| Jun 30, 2023 | 1.47 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 1.70 Mn |
| Sep 30, 2022 | 2.13 Mn |
| Jun 30, 2022 | 1.96 Mn |
| Mar 31, 2022 | 1.20 Mn |